Crozz Friday, 11/16/18 11:21:12 AM Re: None Post # of 3884 Leadership Change...yeah who cares! Hopefully this new CEO can do something of significant value, like secure financing and buy back all the toxic debt. Stop trying to Increase the A/S, just to sell more convertible notes. This company has dug itself a hole that it needs to climb out of on its own. Shareholders are not subsidizing this anymore. How about finding a partner for phase 2-3 trials. This company has no money to make that happen. Maybe just sell the whole company and let us get some losses back or possibly even break even, because the hope of FDA approval is a lost forgone conclusion.